Convergence Investment Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Convergence Investment Partners, LLC

$365 Million
Q3 2024

A detailed history of Convergence Investment Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 522 shares of VRTX stock, worth $262,278. This represents 0.07% of its overall portfolio holdings.

Number of Shares

522

Previous 555 5.95%

Holding current value

$262,278

Previous $260,000 6.92%

% of portfolio

0.07%

Previous 0.08%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$460.0 - $505.78 $15,180 - $16,690	-33 Reduced 5.95%	522 $242,000
Q2 2024 Aug 01, 2024	SELL	$392.81 - $485.53 $295,000 - $364,633	-751 Reduced 57.5%	555 $260,000
Q1 2024 May 03, 2024	BUY	$407.69 - $446.08 $60,338 - $66,019	148 Added 12.78%	1,306 $546,000
Q4 2023 Feb 05, 2024	SELL	$343.0 - $410.68 $55,909 - $66,940	-163 Reduced 12.34%	1,158 $471,000
Q3 2023 Nov 02, 2023	BUY	$338.18 - $362.46 $180,249 - $193,191	533 Added 67.64%	1,321 $459,000
Q2 2023 Jul 26, 2023	SELL	$314.42 - $351.91 $222,923 - $249,504	-709 Reduced 47.36%	788 $277,000
Q1 2023 May 09, 2023	SELL	$283.23 - $323.1 $75,339 - $85,944	-266 Reduced 15.09%	1,497 $472,000
Q4 2022 Feb 03, 2023	SELL	$285.76 - $321.48 $1,428 - $1,607	-5 Reduced 0.28%	1,763 $509,000
Q3 2022 Nov 08, 2022	BUY	$273.83 - $305.53 $123,497 - $137,794	451 Added 34.24%	1,768 $512,000
Q2 2022 Aug 05, 2022	BUY	$234.96 - $292.55 $28,195 - $35,106	120 Added 10.03%	1,317 $371,000
Q1 2022 Apr 26, 2022	BUY	$221.42 - $260.97 $265,039 - $312,381	1,197 New	1,197 $312,000
Q1 2021 Apr 30, 2021	SELL	$207.02 - $241.31 $285,480 - $332,766	-1,379 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$207.01 - $276.09 $285,466 - $380,728	1,379 New	1,379 $326,000
Q2 2018 Aug 07, 2018	SELL	$145.72 - $169.96 $2.17 Million - $2.54 Million	-14,920 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $231,493 - $270,477	1,527 Added 11.4%	14,920 $2.43 Million
Q4 2017 Jan 16, 2018	SELL	$137.28 - $155.55 $77,288 - $87,574	-563 Reduced 4.03%	13,393 $2.01 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $2.07 Million - $2.26 Million	13,956	13,956 $2.12 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.

Account

Convergence Investment Partners, LLC Vertex Pharmaceuticals Inc Transaction History